Epidemiological profile of rheumatoid arthritis
Main Article Content
Keywords
Epidemiology, Rheumatoid, Health Profile, Arthritis
Abstract
Background: Rheumatoid arthritis affects approximately between 0.3 and 1.2% of the world population. In Latin America, different studies have estimated a prevalence between 0.2 and 0.5% in the population over 16 years of age.
Objective: To identify the epidemiological profile of rheumatoid arthritis.
Material and methods: Descriptive cross-sectional design carried out in an urban population of a social security institution in Mexico. The information of the clinical file of 373 patients was studied. The epidemiological profile included the sociodemographic dimension, family history, health, clinical, therapeutic, biochemical, extra-articular manifestations and complications. Statistical analysis percentages, means, confidence intervals for percentages and confidence intervals for averages were calculated.
Results: The wrists were the most affected joints with 44.6% (95% CI: 39.5-49.6%). The extra-articular manifestation with the highest prevalence was asthenia with 9.9% (95% CI: 6.9-12.9%); predominant diagnosis according to ICD-10 was seropositive rheumatoid arthritis with 59.8% (95% CI: 54.8-64.8%), and the rheumatoid factor was highly positive in 78.3% (95% CI: 74.1-82.5%); predominant treatment was with combined therapy at diagnosis in 97.6% (95% CI: 96.0-99.1%). The duration of treatment was > 10 years in 34.1% (95% CI: 29.2-38.8%).
Conclusion: This work has described the epidemiological profile of the patient with rheumatoid arthritis in different dimensions.
References
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature, 2003;423(6937):356-61. doi:10.1038/nature01661.
Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376(9746):1094-108. doi: 10.1016/S0140-6736(10)60826-4.
Combe B, Lukas C, Morel J. Artritis reumatoide del adulto: epidemiología, clínica y diagnóstico. EM Consulte. 2015;48(4):1-17. doi: 10.1016/S1286-935X(15)74992-0.
Carmona L. Epidemiología de la artritis reumatoide. Revista Española de Reumatología. 2002;29(3):86-9. Disponible en: https://www.elsevier.es/es-revista-revista-espanola-reumatologia-29-pdf-13029550.
Kalla AA, Tikly M. Rheumatoid arthritis in the developing world. Best Practice & Research Clinical Rheumatology. 2003;17(5):863-75. doi: 10.1016/S1521-6942(03)00047-0.
Da Mota LMH, Brenol CV, Palominos P, et al. Rheumatoid arthritis in Latin America: the importance of an early diagnosis. Clin Rheumatol. 2015;34(S1):29-44. doi: 10.1007/s10067-015-3015-x.
Massardo L, Suárez-Almazor ME, Cardiel MH, et al. Management of Patients With Rheumatoid Arthritis in Latin America: A Consensus Position Paper From Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio de Artritis Reumatoide. Journal of Clinical Rheumatology. 2009;15(4):203-10. doi: 10.1097/RHU.0b013e3181a90cd8.
McInnes IB. The Pathogenesis of Rheumatoid Arthritis. N Engl J Med. 2011;15. doi: 10.1056/NEJMra1004965.
Turrión Nieves A, Martín Holguera R, Pérez Gómez A, et al. Artritis reumatoide. Medicine. 2017;12(28):1615-25. doi: 10.1016/j.med.2017.02.010.
Morgan C, McBeth J, Cordingley L, et al. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era. Rheumatology. 2015;54(10):1780-91. doi: 10.1093/rheumatology/kev105.
García de Yebenes MJ, Loza E. Artritis reumatoide: epidemiología e impacto sociosanitario. Reumatol Clin. 2018;14(s2):3-6. Disponible en: https://www.reumatologiaclinica.org/es-artritis-reumatoide-epidemiologia-e-impacto-articulo-X1699258X18628548.
Balsa A, Lojo Oliveira L, Alperi López M, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. Reumatología Clínica. 2019;15(2):102-8. doi: 10.1016/j.reuma.2017.06.002.
Morales J, Cázares JM, Gámez Nava JI, et al. La atención médica en reumatología en un hospital de segundo nivel de atención. Reumatol Clin. 2005;1:87-94. doi: 10.1016/S1699-258X(05)72721-2.
Mercado U, Barbosa B. Manifestaciones extraarticulares de artritis reumatoide. Med Int Mex. 2016;32(6):607-11.
Mould Quevedo J, Peláez Ballestas I, Vázquez Mellado J, et al. El costo de las principales enfermedades reumáticas inflamatorias desde la perspectiva del paciente en México. Gac Med Mex. 2008;144(3):225-31.
Espinosa Balderas D, Hernández Sosa MC, Cerdán Galán M. Calidad de vida y capacidad funcional en pacientes con artritis reumatoide. Aten Fam. 2017;24(2):67-71. Disponible en: https://www.medigraphic.com/pdfs/atefam/af-2017/af172e.pdf.
Heimgartnerl E, Rosentha M. La artritis reumatoide en una poblacion indígena (mazahua) del altiplano de México. Bol Of Sanit Panam. 1979;86(4):283-92. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/17371/v86n4p283.pdf?sequence=1.
Peláez Ballestas I, Sanin LH, Moreno Mmontoya J. et al. Epidemiology of the Rheumatic Diseases in Mexico. A Study of 5 Regions Based on the COPCORD Methodology. The Journal of Rheumatology. 2011;86(Supplement):3-8; doi: 10.3899/jrheum.100951.
Bireme. Descriptores en Ciencias de la Salud. Perfil epidemiológico. Disponible en: https://decs.bvsalud.org/es/ths/resource/?id=16859&filter=ths_termall&q=perfil%20epidemiol%C3%B3gico.
Brämer GR. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q. 1988;41(1):32-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/3376487/
Jude AN, González AI. Inmunopatogenia de las enfermedades autoinmunes. Revista Médica Clínica Las Condes. 2012;23(4):464-72. doi: 10.1016/S0716-8640(12)70337-1.
Frisell T, Saevarsdottir S, Askling J. Family history of rheumatoid arthritis: an old concept with new developments. Nat Rev Rheumatol, 2016;12(6):335-43. doi: 10.1038/nrrheum.2016.52.
Reyes Medina EA, Nerey González W, Suárez Rodríguez BL, et al. Caracterización clínico-epidemiológica de los pacientes con artritis reumatoide. Hospital Universitario Arnaldo Milián Castro. Rev Cuba Reumatol. 2015;17(1):17-24. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962015000100004&lng=es.
Cardiel MH. Latin-American Rheumatology Associations of the Pan-American League of Associations for Rheumatology (Panlar), Grupo Latinoamericano de Estudio de ArtritisReumatoide (Gladar), First Latin-American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology (Oxford). 2006;45(s2). doi: 10.1093/rheumatology/kei500.
Montull Morer S, Salvat Salvat I, Novell I, et al. La mano reumatológica:exploración y tratamiento. Revisión. Fisioterapia. 2004:26(2):55-77. doi: 10.1016/S0211-5638(04)73086-2.
Mella LF, Bértolo MB, Dalgalarrondo P. Síntomas depressivos em pacientes con artrite reumatoide. Brazilian Journal of Psychiatry. 2010;32(3):257-63. doi: 10.1590/S1516-44462010005000021.
Acosta MF, López N, Burbano JA, et al. Riesgo cardiovascular en artritis reumatoidea: revisión narrativa. Revista Facultad Ciencias de la Salud. 2017;19(1):27-33. Disponible en: https://revistas.unicauca.edu.co/index.php/rfcs/article/view/166/138.
Cardiel MH, Carrillo S, Pérez M, et al. Actualización de las guías del tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología 2018. Reumatología Clínica. 2019;S1699258X19300798. doi: 10.1016/j.reuma.2019.04.002.
Urquizo Ayala G, Arteaga Coariti R. Diabetes e hiperglicemia inducida por corticoides. Rev Méd La Paz. 2017;23(1):60-8. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582017000100011&lng=es.
Maldonado G, Messina O, Moreno M, et al. Osteoporosis en enfermedades reumáticas e inducidas por glucocorticoides. Revista de Osteoporosis y Metabolismo Mineral. 2017;9(1):38-49. doi: 10.4321/s1889-836x2017000100007.
Zengin O, Onder ME, Kalem A. et al. New inflammatory markers in early rheumatoid arthritis. Z Rheumatol. 2018;77:144-150. doi: 10.1007/s00393-016-0187-y.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.